📌 Key Facts

• Microdosing GLP-1s: Dr. Dubrow recommends microdosing GLP-1 medications like Ozempic and Wegovy, which are typically used in larger doses for diabetes treatment. Microdosing involves taking a steady low dose daily, which may help regulate blood sugar and offer additional health benefits without the risk of significant side effects.
• Health Benefits of GLP-1s: GLP-1 medications not only aid in weight loss but are also linked to reducing the risk of heart disease, kidney disease, and improving metabolic health. Dubrow highlights their effects on insulin regulation and inflammation, suggesting they may even offer cognitive benefits.
• Current Prescription Practices: Microdosing is considered an off-label use of GLP-1s, and while Dubrow supports it, he notes that many healthcare providers may be reluctant to prescribe these medications for non-standard uses. He indicates a trend among younger populations exploring microdosing for broader health improvement.
• Safeguards and Risks: Despite the potential benefits, Dubrow warns about the risks, including gastrointestinal issues and a rare chance of thyroid cancers associated with GLP-1 drugs. He emphasizes the need for proper medical guidance and monitoring when using these medications.
• Future of GLP-1 Medications: Dubrow forecasts that advancements in GLP-1 medications will continue, predicting the development of new drugs aimed at manipulating hunger and insulin resistance in more effective ways within the next few years.

📂 Article Classification

📍 Location